Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus
International Journal of Rheumatic Diseases · 2023-04 · 26 (4) · 667-672
DOI: 10.1111/1756-185x.14606 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 17.02.2023. Verfasst von Pornsawan Leosuthamas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. Hauptthemen laut MEDLINE: Lupus Nephritis, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Objective
Disease activity measures in systemic lupus erythematosus (SLE) are critical tools for trial endpoints. We aimed to evaluate the performance of current treatment outcome measures in SLE.
Methods
Individuals with active SLE with a clinical SLE Disease Activity Index‐2000 (SLEDAI‐2K) score of at least 4 were followed up for two or more visits and classified as responders and non‐responders based on a physician's judgment of improvement. The treatment outcome measures including SLEDAI‐2K responder index‐50 (SRI‐50), SLE responder index‐4 (SRI‐4), substituting SLEDAI‐2K with SRI‐50 in SRI‐4 (SRI‐4(50)), SLE Disease Activity Score (SLE‐DAS) responder index (Δ ≥ 1.72) and the British Isles Lupus Assessment Group (BILAG)‐based Composite Lupus Assessment (BICLA) were tested. The performance of those measures was shown by sensitivity, specificity, predictive value, positive likelihood ratio, accuracy, and agreement against a physician‐rated improvement.
Results
Twenty‐seven patients with active SLE were followed. The total cumulative pair of visits (baseline and follow up) was 48. The overall accuracies (95% confidence interval [CI]) of SRI‐50, SRI‐4, SRI‐4(50), SLE‐DAS, and BICLA for detecting responders in all patients were 72.9 (58.2‐84.7), 75.0 (60.4‐86.4), 72.9 (58.2‐84.7), 75.0 (60.4‐86.4), and 64.6 (49.5‐77.8), respectively. Subgroup analyses of lupus nephritis (23 patients had a pair of visits) found the accuracies (95% CI) of SRI‐50, SRI‐4, SRI‐4(50), SLE‐DAS, and BICLA were 82.6 (61.2‐95.0), 73.9 (51.6‐89.8), 82.6 (61.2‐95.0), 82.6 (61.2‐95.0), and 78.3 (56.3‐92.5), respectively. However, there were no significant differences between the groups ( P > 0.05).
Conclusion
SRI‐4, SRI‐50, SRI‐4(50), SLE‐DAS responder index, and BICLA demonstrated comparable abilities to identify clinician‐rated responders in patients with active SLE and lupus nephritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
ORCID-Profile: Pongthorn Narongroeknawin, Sumapa Chaiamnuay, Rattapol Pakchotanon
Zitieren
APA
Leosuthamas, P., Narongroeknawin, P., Chaiamnuay, S., Asavatanabodee, P., & Pakchotanon, R. (2023). Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus. International Journal of Rheumatic Diseases, 26(4), 667-672. https://doi.org/10.1111/1756-185x.14606
Vancouver
Leosuthamas P, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R. Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus. International Journal of Rheumatic Diseases. 2023;26(4):667-672. doi:10.1111/1756-185x.14606
BibTeX
@article{Leosuthamas2023,
author = {Leosuthamas, Pornsawan and Narongroeknawin, Pongthorn and Chaiamnuay, Sumapa and Asavatanabodee, Paijit and Pakchotanon, Rattapol},
title = {Performance of systemic lupus erythematosus responder index for detecting clinician‐rated responders in patients with active systemic lupus erythematosus},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
volume = {26},
number = {4},
pages = {667--672},
doi = {10.1111/1756-185x.14606}
}
EUVIMED